Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
/bioconjugation technology companies; and/or, (ii) have experience in antibody conjugation, bioconjugation chemistry, protein engineering, or antibody-drug conjugate (ADC) development. For more information about
-
5 Sep 2026 Job Information Organisation/Company CNRS Department Institut de Pharmacologie Moléculaire et Cellulaire Research Field Pharmacological sciences Engineering Technology Researcher Profile
-
equivalencies: https://hr.uky.edu/employment/working-uk/equivalencies Required Related Experience No experience required. Required License/Registration/Certification American Society for Clinical Pathology (ASCP
-
strong publication record in peer-reviewed journals. Desired Requirements: Experience in virology study, antibody functional analysis. Prior work on antibody engineering or rational design. Experience
-
platforms for the development of human antibodies and other relevant molecules for therapy. The position is linked to CREATE Health , which is a center dedicated to using advanced technology to advance cancer
-
establish alternative experimental models to animal testing (NAM). The work will be carried out on the INGESYSBIO meta-platform: Engineering of native or reconstructed biological systems (https://bmbi.utc.fr
-
University of California, Los Angeles | Los Angeles, California | United States | about 18 hours ago
projects in the laboratory integrate whole-genome sequencing (WGS), transcriptomics, single-cell RNA sequencing, antibody and systems-serology measurements, PhIP-Seq/epitope profiling, immunophenotyping, and
-
HLA biology, immunopeptidomics, HLA-E biology, peptide-MHC recognition, and TCR-mimic (TCRm) antibody discovery and engineering. The cluster is centered on the scientific premise that intracellular
-
, and first in human translation. Job Description Primary Duties & Responsibilities: Information on being a postdoc at WashU in St. Louis can be found at https://postdoc.wustl.edu/prospective-postdocs-2
-
multidisciplinary, NIH-funded research program at the interface of molecular imaging, antibody engineering, cancer biology, drug development, and translational oncology. Our laboratory develops next-generation